Biotech entity
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention AstraZeneca, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.5 across the same-window beat baseline. At 6, the average consequence score sits above the same-window beat average of 5.7.
Last mentioned: Aug 1, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention AstraZeneca, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.5 across the same-window beat baseline. At 6, the average consequence score sits above the same-window beat average of 5.7. U.S. Circuit Judge Harris appears in 1 tracked Biotech story from August 1, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering U.S. Circuit Judge Harris. Shared-story counts are live from our verified record — not editorial picks.
The Tenth Circuit's decision reaffirms clinical trial sponsors' liability protections under the PREP Act, but a pending waiver analysis could impact how pharmaceutical companies draft informed consent forms.
Source: saltlakecitysun.com · utahindependent.com
U.S. Circuit Judge Harris is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
